Nasivin, 0.025% 10 ml drops
€6.55 €5.82
Nasivin® (oxymetazoline) has a vasoconstrictor effect. When applied topically on inflamed nasal mucosa it reduces its swelling and nasal discharge. Restores nasal breathing. Elimination of mucous membrane edema restores aeration of paranasal sinuses and middle ear cavity which prevents from development of bacterial complications (maxillary sinusitis, sinusitis, otitis media).
In case of local intranasal application at therapeutic concentrations it does not irritate mucosa and does not cause hyperemia. During local intranasal administration the drug does not have a systemic effect. The drug starts acting quickly (within a few minutes). The duration of action of Nazivin is up to 12 hours.
Indications
Allergic rhinitis, Colds, Flu, Sinusitis, Pollinosis, Runny nose, Nasal congestion, Otitis media
- Treatment of acute respiratory diseases accompanied by runny nose;
- Allergic rhinitis;
- Rhinitis.rhinitis vasomotor;
- to restore drainage in case of inflammation of paranasal sinuses, eustachitis, otitis media;
- to eliminate edema before diagnostic manipulations of the nasal passages.
.
Active ingredient
Oxymetazoline
Composition
1 ml of the drug contains:
Active ingredient:
Nasivin 0.01% – Oxymetazoline hydrochloride 0.1 mg
Nasivin 0.025% – Oxymetazoline hydrochloride 0.25 mg
benzalkonium chloride 50% solution,
diethate dihydrate,
sodium dihydrophosphate dihydrate,
How to take, the dosage
Nazivin® 0,01 %, 0,025 % and 0,05 % drops are intended for nasal application.
Adults and children over 6 years of age: apply Nazivin® 0,05 % drops 1 – 2 drops into each nostril 2 – 3 times a day.
Children from 1 year old to 6 years old: apply Nazivin® 0,025 % drops 1 – 2 drops into each nostril 2 – 3 times a day.
Children under 1 year of age: children under 4 weeks of age are prescribed 1 drop of Nazivin® 0,01 % in each nostril 2 – 3 times a day. From the 5th week of life and up to 1 year – 1 to 2 drops in each nostril 2 to 3 times a day.To ensure accurate dosage, the bottle of Nazivin® 0.01% drops has a graduated dropper with markings of the number of drops. For example, if 1 drop is prescribed, the pipette should be filled with the solution to the mark 1. The following procedure has also been proven to be effective: depending on the age 1 to 2 drops of 0.01 % solution are put on absorbent cotton and wiped nasal passages.
Nasivin® 0.01 %, 0.025 % and 0.05 % drops should be used for 3 to 5 days.
Doses above the recommended ones should be used only under medical supervision.
Interaction
In concomitant administration of MAOI blockers and tricyclic antidepressants – increase in blood pressure. Concomitant administration of other vasoconstrictor drugs increases the risk of side effects.
Special Instructions
Long-term use and overdose of the drug should be avoided, especially in children.
Contraindications
Atrophic rhinitis; closed-angle glaucoma; hypersensitivity to the drug components. The recommended concentrations of the drug for different age categories should be adhered to (see routes of administration).
With caution
In patients taking monoamine oxidase inhibitors and other drugs that contribute to increased blood pressure for up to 10 days after their use; In patients with increased intraocular pressure, during pregnancy and lactation, in severe forms of cardiovascular diseases (hypertension, angina pectoris); in thyrotoxicosis and diabetes.
Side effects
Sometimes: burning or dry nasal membranes, sneezing.
In rare cases: after the effect of using Nazivin® passes, a strong feeling of “stuffy” nose (reactive hyperemia). Repeated overdose with topical nasal use sometimes leads to systemic sympathomimetic effects such as increased pulse rate (tachycardia) and increased blood pressure.
In very rare cases, anxiety, insomnia, fatigue, headaches and nausea have been observed.
Prolonged continuous use of vasoconstrictors can lead to tachyphylaxis, nasal mucosal atrophy and recurrent nasal mucosal edema (medicated rhinitis).
Overdose
Symptoms: In significant overdose or ingestion, constriction of the pupils, nausea, vomiting, cyanosis, increased body temperature, tachycardia, arrhythmia, collapse, cardiac depression, arterial hypertension, pulmonary edema, respiratory distress may be observed.
In addition, mental disorders may be observed, as well as depression of CNS function accompanied by somnolence, decreased body temperature, bradycardia, arterial hypotension, respiratory arrest and possible development of coma.
Treatment:Gastric lavage, administration of activated charcoal.
Pregnancy use
When using during pregnancy or breastfeeding do not exceed the recommended dosage.
Similarities
Afrin, Nasivin, Nasol, Otrivin, Nasol Advance, Nasivin Sensitive, Rinostop, Nesopin, Oxyfrine, Sialor, Rinostop Extra, Cold and Flu, No Time to Be Sick
Weight | 0.046 kg |
---|---|
Shelf life | 3 years |
Conditions of storage | Store at a temperature not exceeding 25 °C. |
Manufacturer | Sofarimex Industria Quimica e Pharmasuetica S.A., Portugal |
Medication form | nasal drops |
Brand | Sofarimex Industria Quimica e Pharmasuetica S.A. |
Other forms…
Related products
Buy Nasivin, 0.025% 10 ml drops with delivery to USA, UK, Europe and over 120 other countries.